NEW YORK (GenomeWeb) – As the diagnostics industry awaits the release of final regulations for lab-developed tests, some laboratories are banking on commercially available analyte-specific reagents (ASRs) as a means of simplifying their work and as a key enabler in responding to critical patient needs when tests are not otherwise available.

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.